Haleon Pakistan has announced a fresh investment of $12 million to expand its manufacturing capacity, focusing on scaling up ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

SAP reported a remarkable 28% year-on-year increase in cloud revenue, primarily driven by the Cloud ERP Suite, which itself grew by 34% in Q2. The current cloud backlog also saw a significant rise, ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the ...

These stories show how volatility in global markets is pushing manufacturers to make painful workforce decisions.

EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory ...

The second quarter of 2025 got off to a rocky start, as higher-than-expected U.S. tariff announcements weighed heavily on ...

According to the latest study from BCC Research, "Biologic Therapeutic Drugs: Technologies and Global Markets" is projected ...